Poster abstracts
The planning committee for the 2026 ADLM International CPOCT Symposium thanks you for your poster abstract submissions. Authors of accepted abstracts will be invited to display their poster(s) during the conference and must register to do so.
Key details and dates
- The deadline for abstract submission was August 28, 2026.
- Acceptance notices will be sent by September 4.
- Authors of accepted abstracts must confirm participation and register by September 14. Please note that authors will need to present their posters at the conference in person to be included in the abstract publication.
- Submitters of the top poster abstract submissions will be invited to present their work as a 15-minute oral presentation to an audience of thought-leaders and peers in addition to displaying their poster(s) during the conference.
- Presented poster abstracts will be published as a supplement issue in ADLM's online peer-reviewed publication, The Journal of Applied Laboratory Medicine (JALM).
Registration
Presenting authors are required to register as conference attendees and present their posters in person. Any requests to change the presenting author must be made in writing to [email protected] by September 14 for consideration. Poster abstracts will not be included in program materials or JALM supplement until registration and attendance of the presenting author is confirmed.
Withdrawal
If you plan to withdraw your abstract, please notify [email protected] in writing as soon as possible including the abstract title and author name.
Publication and presentation
All accepted posters will be published as a supplement in the ADLM's online peer-reviewed publication, The Journal of Applied Laboratory Medicine (JALM). Additional details on poster preparation will be provided after notices are sent September.
Poster preparation guidelines & requirements
Poster size and display board
ADLM does not provide poster printing services. It is the responsibility of poster presenters to prepare and print their poster(s) for display on the provided poster boards. Please review the size and space information carefully as you prepare your poster.
- The maximum size for an accepted poster is 46 inches (117 cm) x 46 inches (117 cm). If your poster exceeds the limit, it may be cut, folded, or otherwise modified to permit the allotted display room.
- The poster abstract number provided by ADLM will be placed in the upper corner and measures 8.5 inches wide by 5.5 inches high (approximately 22 cm x 14 cm).
Required poster information
Each accepted poster must contain the following information:
- Title as submitted in your abstract submission.
- Presenting author and all co-authors.
- Author(s) affiliation(s).
- Background of your study (why you did this work).
- Method(s) used to achieve a solution.
- Results obtained (figures, tables, etc.).
- Conclusions and importance of your work to laboratory medicine.
Please note that ADLM only provides the poster abstract number placed in the upper corner. It is the responsibility of the poster presenter to print and display their poster(s) at the designated times.
General poster guidance
- The information you display should have a professional appearance.
- All information should be easily read from at least 5 feet away from your poster.
- Headings for abstract title and numbering for subsections should be a minimum of 72 pt font (approximately 1 inch or 2.5 cm height).
- Subheadings should be a minimum of 36 pt font (approximately 0.5 inches or 1 cm height).
- All type should be a minimum of 24 pt font (approximately 0.3 inches or 0.8 cm height) and readable from a distance of 5-7 feet (1.5-1.7 meters).
Restrictions
- Instruments, components, or reagents are NOT permitted in the poster area.
Poster session schedule
You are required to set up your poster between 5 – 6 pm on Wednesday, October 14, 2026. Please collect your badge at the registration table and identify your poster number for your spot in the poster presentation section.
Your poster is to remain on display for the entire duration of the conference and removed by Friday, October 16, 2026 by 4:30 pm.
ADLM is not responsible for posters left on boards after the conference concludes.
List of accepted scientific poster abstracts
Accepted posters are listed in alphabetical order, by last name. Poster numbers will be assigned before the conference. Poster presentations will be on display starting Wednesday, October 14 at 6:00 pm. Poster displays conclude at the end of the conference on Friday, October 16 at 4:30 pm.
Direct-to-Consumer Testing
1 | Characterization of Upper Arm Capillary Blood Collection Performance: Effects of Pre-Warming, Collection Site, and Collection Order
Michelle Seaton, Dynacare, Brampton, Ontario, Canada
New and Emerging Technologies
2 | Closing the Loop at the Primary Care Unit: Integrating Point-of-Care Testing, Multi-Frequency Vibrometry, Continuous Glucose Monitoring, and Device-Assisted Neurorehabilitation into Thailand's Nationwide POCT-Telehealth Network
Gerald Kost, University of California, Davis, Davis, CA, United States
3 | Evaluation of a Whole Blood Point-of-Care Test for Traumatic Brain Injury in the Emergency Care Setting
Joshua Pantanowitz, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
4 | Generative artificial intelligence use, comfort, and implementation priorities among point-of-care testing professionals: an international survey
Joshua Pantanowitz, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
5 | A Validated Smartphone-Based Platform for application in Quantitative Point-of-Care and At-home Testing of Total Cholesterol and Triglycerides in a colorimetric paper-microfluidic assay
Prava Sharma, HueDx Inc., Philadelphia, PA, United States
6 | Complexity behind the waiver: real-world perspectives and framework for successful implementation of emerging point-of-care technologies from a large healthcare network
Jesse Young, TriCore Reference Laboratories, Albuquerque, NM, United States
Outcome-Based Testing in Various Healthcare Settings
7 | Testing Smarter: Cost savings from a rapid, risk-stratified Syndromic Respiratory solution (BIOFIRE® SPOTFIRE® R/ST Panel) in high-risk urgent care patients
Federico Cairoli, bioMerieux, Marcy-L'etoile, France
8 | From Complexity to Compliance: Leveraging Technology for Competency Management in a Large POCT Network
Leh Chang, Loma Linda University Medical Center Clinical Laboratory, Loma Linda, CA, United States
9 | TriVerity rapid host response testing in adult emergency department patients with suspected acute infection: an interventional study
Gaby Dashler, Johns Hopkins University, Baltimore, MD, United States
10 | Integrating a Real-Time Data Management Point-of-Care (POC) Connectivity Solution into Hospital Diabetes Outpatient Clinic POC Testing Workflow
Malerie Goh, Sengkang General Hospital, Singapore, Singapore
11 | Feasibility of a Recent FDA-Cleared, CLIA-Waived Point-of-Care Hepatitis C Virus RNA Test in a U.S. Urban Emergency Department
Kevin Zhang, Johns Hopkins University School of Medicine, Baltimore, MD, United States
Molecular Diagnostics, Infectious Diseases, and Toxicology
12 | HELIX-LAMP: A Portable Isothermal Nucleic Acid Amplification Platform for Rapid Field Diagnostics
Ayesha Azimuddin, HueDx, Philadelphia, PA, United States
13 | Fast, sensitive, and culture-independent: Molecular point-of-care detection of Group A Streptococcus
Brian Bernier, Luminex, Austin, TX, United States
14 | Comparative assessment of PCR-based and rapid antigen testing for group A Streptococcus in an integrated health system
Kelsey Lyons, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
15 | Beyond the Lab: Usability of an FDA-Cleared Host-Response Point-of-Care Device Among Non-Laboratory Certified Personnel
Breana McBryde, Johns Hopkins School of Medicine, Baltimore, MD, United States
Emergency Preparedness and Resource-Limited Settings
16 | Development and Characterization of Human Plasma-Based Internal Quality Control Materials for HIV Point-of-Care Testing
Napaporn Apiratmateekul, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand
17 | A handheld plasma separator suitable for multimodal blood tests in remote settings
Meng Sun, MicroFAST Dx, Durham, NC, United States
18 | Toward AI-enabled differentiation of dengue and influenza using routine CBC data for point-of-care decision support
Kittisak Thawnashom, Naresuan University, Phitsanulok, Thailand
Chronic and Acute Disease Management
19 | Creatinine Discordance Prior to Contrast-Enhanced CT: Implications of Point-of-Care Versus Central Laboratory Testing
Melissa Ulas, Temple University Health System, Philadelphia, PA, United States
Practical Applications of POCT
20 | Pilot Study of SOFIA POCT Rapid Lyme Disease Test in Pediatric Emergency Settings Compared to Routine LIASON Workflow
Magdalena Baumgartner, WVU Medicine, Morgantown, WV, United States
21 | Systematic Comparison of Electrolyte Measurements in POCT versus Central Laboratory Analyzers: Implications for Critical Decisions in ICU
Jayeeta Bhadra, Vallabhbhai Patel Chest Institute, North Delhi, India
22 | Point-of-care viscoelastic testing reduces length of stay and blood product utilization in cardiac surgery patients
Sean Carey, Deborah Heart and Lung Center, Browns Mills, NJ, United States
23 | Reducing Documentation Errors in Point of care Testing: A practical PDCA-Based Approach to Improve Compliance in Clinical Settings
Scarlin Chavarria, Jackson Health System, Miami, FL, United States
24 | Use of a Binary Clinical Decision-Making Process to Reconcile Medical Decision Point Method Differences in Activated Clotting Time Tests to Assist in Method Crossover Interpretation
Alex Chin, Brigham and Women's Hospital/Mass General Brigham/Harvard Medical School, Boston, MA, United States
25 | High User Satisfaction and Workflow Improvement Following Implementation of Molecular Point-of-Care Testing in the Emergency Department
Kim Evans, University of South Alabama, Children's and Women’s Hospital, Mobile, AL, United States
26 | From Planning to Go-Live: Practical Takeaways from Migrating to a New Point-of-Care (POC) Middleware Connectivity
Malerie Goh, Sengkang General Hospital, Singapore, Singapore
27 | High Burden of Positive Cannabinoid Screens in a Pediatric Emergency Department Supports the Need for Point-of-Care Testing
Sarah Grubb, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, United States
28 | Implementation of New POC Analyzers: Importance of Postimplementation Follow-up
Monica Ianosi-Irimie, Cooper Medical School of Rowan University, Camden, NJ, United State
29 | Beyond the “Meter Disinfected” Button: A Proactive Quarterly Audit Approach to Glucometer Disinfection For Patient Safety
Nichole Korpi-Steiner, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
30 | A multisite analysis of waste generation from 100,000 blood gas analysis tests
Nicholas Larkey, University of Virginia, Charlottesville, VA, United States
31 | Transforming Ambulatory Point-of-Care Testing Through Network-Wide Standardization
Lana Lyle, Allegheny Health Network, Pittsburgh, PA, United States
32 | Cost-Analysis for Transportable versus Handheld Point-of-Care Whole Blood Analysis
Brina Ratangee, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
33 | An Evaluation of Factors Influencing i-STAT Device Lifespan
Tiffany Stenzel, HealthPartners, Saint Paul, MN, United States
34 | To Transfuse or Not to Transfuse: Are Point-of-Care Haemoglobin Results Fit for Transfusion Decision-Making?
Carol Hui Chen Tan, Singapore General Hospital, Singapore, Singapore
35 | Extrinsic clot time concordance between Quantra® QPlus® and ROTEM® delta in the cardiopulmonary context
Caroline Wang, HemoSonics, Durham, NC, United States
Questions?
Email [email protected].